---
title: ConsortiEX Blog | compounded sterile productions
description: compounded sterile productions |
---

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png "ConsortiEX")](https://www.consortiex.com)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

# ConsortiEX Blog

- [ConsortiEX](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA](https://info.consortiex.com/blog/tag/dqsa)
- [FDA](https://info.consortiex.com/blog/tag/fda)
- [Compounding](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)

[![Take Control of Patient Safety and Quality Control with InsightRX](https://info.consortiex.com/hs-fs/hubfs/IMG_1129.jpg?width=788&name=IMG_1129.jpg)](https://info.consortiex.com/blog/ashp18-patient-safety-quality-control)

December 4, 2018

## [Take Control of Patient Safety and Quality Control with InsightRX](https://info.consortiex.com/blog/ashp18-patient-safety-quality-control)

Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.

[Read More](https://info.consortiex.com/blog/ashp18-patient-safety-quality-control)

[![Address Quality Control, Re-insourcing CSP Production with a Central Fill Model](https://info.consortiex.com/hs-fs/hubfs/patient-safty.jpg?width=788&name=patient-safty.jpg)](https://info.consortiex.com/blog/enhance-patient-safety-re-insourcing-cps-production-central-fill-model)

December 2, 2018

## [Address Quality Control, Re-insourcing CSP Production with a Central Fill Model](https://info.consortiex.com/blog/enhance-patient-safety-re-insourcing-cps-production-central-fill-model)

Today, cost and quality issues surrounding compounded sterile preparations (CSP’s) have nearly every major health system investigating what it takes to re-insource production. Most are looking at a hub and spoke approach, where their central-fill Batch Compounding can support the CSP production needs of all the\[...\]

[Read More](https://info.consortiex.com/blog/enhance-patient-safety-re-insourcing-cps-production-central-fill-model)

[![FDA Commissioner Details Steps to Ensure the Quality of and Preserve Access to Compounded Drugs](https://info.consortiex.com/hs-fs/hubfs/fdalogo-3.png?width=788&name=fdalogo-3.png)](https://info.consortiex.com/blog/fda-commissioner-statement)

September 11, 2018

## [FDA Commissioner Details Steps to Ensure the Quality of and Preserve Access to Compounded Drugs](https://info.consortiex.com/blog/fda-commissioner-statement)

The practice of compounding medicines can provide important public health opportunities. The FDA’s compounding program – including implementation of the compounding provisions of the law – is a priority for the agency. We recognize that in delivering on implementation commitments, we must balance the need to preserve\[...\]

[Read More](https://info.consortiex.com/blog/fda-commissioner-statement)

[![Thanks for stopping by the ConsortiEX booth to discover the power of our Pharmacy-Focused ERP.](https://info.consortiex.com/hs-fs/hubfs/Rx-focus-ERP-2.jpg?width=788&name=Rx-focus-ERP-2.jpg)](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

June 7, 2018

## [Thanks for stopping by the ConsortiEX booth to discover the power of our Pharmacy-Focused ERP.](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.

[Read More](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

[![ConsortiEX CEO Neal Long Talks Patient Safety](https://info.consortiex.com/hs-fs/hubfs/in-wisconsin-logo.jpg?width=788&name=in-wisconsin-logo.jpg)](https://info.consortiex.com/blog/consortiex-ceo-neal-long)

October 16, 2014

## [ConsortiEX CEO Neal Long Talks Patient Safety](https://info.consortiex.com/blog/consortiex-ceo-neal-long)

We recently sat down with ConsortiEX CEO, Neal Long, to discuss the company’s background and learn more about its plans to help hospitals safely distribute, source and track compounded pharmaceuticals among affiliated hospitals. addresses the worldwide problem of drug availability, patient safety and high costs. The\[...\]

[Read More](https://info.consortiex.com/blog/consortiex-ceo-neal-long)

[1](https://info.consortiex.com/blog/tag/compounded-sterile-productions/page/1)

### Recent Posts

- [In Response to the FDA Announcement](https://info.consortiex.com/blog/in-response-to-the-fda)   
  October 11, 2024
- [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)   
  August 6, 2024
- [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)   
  March 13, 2024

### Topics

- [ConsortiEX (22)](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA (21)](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA (18)](https://info.consortiex.com/blog/tag/dqsa)
- [FDA (18)](https://info.consortiex.com/blog/tag/fda)
- [Compounding (17)](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding (16)](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act (16)](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)
- [patient safety (16)](https://info.consortiex.com/blog/tag/patient-safety)
- [assure-trak (15)](https://info.consortiex.com/blog/tag/assure-trak)
- [Blog (14)](https://info.consortiex.com/blog/tag/blog)
- [Track and Trace (13)](https://info.consortiex.com/blog/tag/track-and-trace)
- [Drug Supply Chain Security Act (12)](https://info.consortiex.com/blog/tag/drug-supply-chain-security-act)
- [IV workflow software (12)](https://info.consortiex.com/blog/tag/iv-workflow-software)
- [Industry (12)](https://info.consortiex.com/blog/tag/industry)
- [Pharmacy IT software (11)](https://info.consortiex.com/blog/tag/pharmacy-it-software)
- [health care pharmacy (11)](https://info.consortiex.com/blog/tag/health-care-pharmacy)
- [iv workflow (11)](https://info.consortiex.com/blog/tag/iv-workflow)
- [503B (10)](https://info.consortiex.com/blog/tag/503b)
- [503A (9)](https://info.consortiex.com/blog/tag/503a)
- [compliance (9)](https://info.consortiex.com/blog/tag/compliance)
- [iv workflow management (9)](https://info.consortiex.com/blog/tag/iv-workflow-management)
- [Total Ingredient Life Cycle (8)](https://info.consortiex.com/blog/tag/total-ingredient-life-cycle)
- [enterprise resource planning (8)](https://info.consortiex.com/blog/tag/enterprise-resource-planning)
- [pedigree to patient (8)](https://info.consortiex.com/blog/tag/pedigree-to-patient)
- [pharmacy software (8)](https://info.consortiex.com/blog/tag/pharmacy-software)
- [traceability (8)](https://info.consortiex.com/blog/tag/traceability)
- [USP (7)](https://info.consortiex.com/blog/tag/usp)
- [anticipatory compounding (7)](https://info.consortiex.com/blog/tag/anticipatory-compounding)
- [assure-track (6)](https://info.consortiex.com/blog/tag/assure-track)
- [pharmaceutical compounding (6)](https://info.consortiex.com/blog/tag/pharmaceutical-compounding)
- [Spotlight (5)](https://info.consortiex.com/blog/tag/spotlight)
- [compounded sterile preparations (5)](https://info.consortiex.com/blog/tag/compounded-sterile-preparations)
- [compounded sterile productions (5)](https://info.consortiex.com/blog/tag/compounded-sterile-productions)
- [pharmacy (5)](https://info.consortiex.com/blog/tag/pharmacy)
- [pharmacy it (5)](https://info.consortiex.com/blog/tag/pharmacy-it)
- [quality assurance (5)](https://info.consortiex.com/blog/tag/quality-assurance)
- [DSCSA Compliance (4)](https://info.consortiex.com/blog/tag/dscsa-compliance)
- [EDI (4)](https://info.consortiex.com/blog/tag/edi)
- [News (4)](https://info.consortiex.com/blog/tag/news)
- [T3 Documentation (4)](https://info.consortiex.com/blog/tag/t3-documentation)
- [USP 797 (4)](https://info.consortiex.com/blog/tag/usp-797)
- [clean room (4)](https://info.consortiex.com/blog/tag/clean-room)
- [compounded IV bags (4)](https://info.consortiex.com/blog/tag/compounded-iv-bags)
- [compounded syringe (4)](https://info.consortiex.com/blog/tag/compounded-syringe)
- [drug serialization (4)](https://info.consortiex.com/blog/tag/drug-serialization)
- [order management (4)](https://info.consortiex.com/blog/tag/order-management)
- [sterile product compounding (4)](https://info.consortiex.com/blog/tag/sterile-product-compounding)
- [transaction history transaction information transa (4)](https://info.consortiex.com/blog/tag/transaction-history-transaction-information-transa)
- [DQSA - USP 797 (3)](https://info.consortiex.com/blog/tag/dqsa-usp-797)
- [DSCSA CaaS (3)](https://info.consortiex.com/blog/tag/dscsa-caas)
- [DSCSA Software (3)](https://info.consortiex.com/blog/tag/dscsa-software)
- [Drug Counterfeiting (3)](https://info.consortiex.com/blog/tag/drug-counterfeiting)
- [EPCIS (3)](https://info.consortiex.com/blog/tag/epcis)
- [Requirements (3)](https://info.consortiex.com/blog/tag/requirements)
- [drug borrow loan (3)](https://info.consortiex.com/blog/tag/drug-borrow-loan)
- [dscsa compliance as a service 3T (3)](https://info.consortiex.com/blog/tag/dscsa-compliance-as-a-service-3t)
- [exchange (3)](https://info.consortiex.com/blog/tag/exchange)
- [guidance (3)](https://info.consortiex.com/blog/tag/guidance)
- [illegitimate product (3)](https://info.consortiex.com/blog/tag/illegitimate-product)
- [pharmacy erp (3)](https://info.consortiex.com/blog/tag/pharmacy-erp)
- [suspect product (3)](https://info.consortiex.com/blog/tag/suspect-product)
- [3Ts (2)](https://info.consortiex.com/blog/tag/3ts)
- [ASHP (2)](https://info.consortiex.com/blog/tag/ashp)
- [COVID-19 (2)](https://info.consortiex.com/blog/tag/covid-19)
- [Compliance as a Service (2)](https://info.consortiex.com/blog/tag/compliance-as-a-service)
- [Compounding Pharmacy (2)](https://info.consortiex.com/blog/tag/compounding-pharmacy)
- [DSCSA service (2)](https://info.consortiex.com/blog/tag/dscsa-service)
- [DSCSA software and service (2)](https://info.consortiex.com/blog/tag/dscsa-software-and-service)
- [Data Entry (2)](https://info.consortiex.com/blog/tag/data-entry)
- [Drug supply chain transparency (2)](https://info.consortiex.com/blog/tag/drug-supply-chain-transparency)
- [Electronic Data Interchange (2)](https://info.consortiex.com/blog/tag/electronic-data-interchange)
- [Environmental monitoring (2)](https://info.consortiex.com/blog/tag/environmental-monitoring)
- [Manual T3 Conversion (2)](https://info.consortiex.com/blog/tag/manual-t3-conversion)
- [NDC tracking (2)](https://info.consortiex.com/blog/tag/ndc-tracking)
- [Passive auditing (2)](https://info.consortiex.com/blog/tag/passive-auditing)
- [Prescription tracking (2)](https://info.consortiex.com/blog/tag/prescription-tracking)
- [T3 (2)](https://info.consortiex.com/blog/tag/t3)
- [T3 Conversion (2)](https://info.consortiex.com/blog/tag/t3-conversion)
- [T3s (2)](https://info.consortiex.com/blog/tag/t3s)
- [compounded IV bag (2)](https://info.consortiex.com/blog/tag/compounded-iv-bag)
- [compounded syringes (2)](https://info.consortiex.com/blog/tag/compounded-syringes)
- [drug supply chain (2)](https://info.consortiex.com/blog/tag/drug-supply-chain)
- [drug transfers (2)](https://info.consortiex.com/blog/tag/drug-transfers)
- [dscsa deadline (2)](https://info.consortiex.com/blog/tag/dscsa-deadline)
- [fda guidance (2)](https://info.consortiex.com/blog/tag/fda-guidance)
- [patient specific compounding (2)](https://info.consortiex.com/blog/tag/patient-specific-compounding)
- [pharmacy serialization (2)](https://info.consortiex.com/blog/tag/pharmacy-serialization)
- [pharmacy supply chain (2)](https://info.consortiex.com/blog/tag/pharmacy-supply-chain)
- [product (2)](https://info.consortiex.com/blog/tag/product)
- [product identifier (2)](https://info.consortiex.com/blog/tag/product-identifier)
- [quarantine (2)](https://info.consortiex.com/blog/tag/quarantine)
- [regulation (2)](https://info.consortiex.com/blog/tag/regulation)
- [serialization (2)](https://info.consortiex.com/blog/tag/serialization)
- [sterile injectable compound (2)](https://info.consortiex.com/blog/tag/sterile-injectable-compound)
- [vaccine (2)](https://info.consortiex.com/blog/tag/vaccine)
- [503B. outsourcing facility (1)](https://info.consortiex.com/blog/tag/503b-outsourcing-facility)
- [Bar Code Medication Verification (1)](https://info.consortiex.com/blog/tag/bar-code-medication-verification)
- [Central Sterile Compounding (1)](https://info.consortiex.com/blog/tag/central-sterile-compounding)
- [Cleanroom (1)](https://info.consortiex.com/blog/tag/cleanroom)
- [Compounding Quality Act (1)](https://info.consortiex.com/blog/tag/compounding-quality-act)
- [ISMP (1)](https://info.consortiex.com/blog/tag/ismp)
- [Pharmacy Informatics (1)](https://info.consortiex.com/blog/tag/pharmacy-informatics)
- [Technology Assisted IV Workflow Software (1)](https://info.consortiex.com/blog/tag/technology-assisted-iv-workflow-software)
- [USP . USP 800 (1)](https://info.consortiex.com/blog/tag/usp-usp-800)
- [audit (1)](https://info.consortiex.com/blog/tag/audit)
- [barcode (1)](https://info.consortiex.com/blog/tag/barcode)
- [central-fill (1)](https://info.consortiex.com/blog/tag/central-fill)
- [community involvement (1)](https://info.consortiex.com/blog/tag/community-involvement)
- [compounding management system (1)](https://info.consortiex.com/blog/tag/compounding-management-system)
- [deadline (1)](https://info.consortiex.com/blog/tag/deadline)
- [draft guidance (1)](https://info.consortiex.com/blog/tag/draft-guidance)
- [drug loan borrow (1)](https://info.consortiex.com/blog/tag/drug-loan-borrow)
- [drug waste (1)](https://info.consortiex.com/blog/tag/drug-waste)
- [dynamic patient specific (1)](https://info.consortiex.com/blog/tag/dynamic-patient-specific)
- [grandfathered (1)](https://info.consortiex.com/blog/tag/grandfathered)
- [grandfathered product (1)](https://info.consortiex.com/blog/tag/grandfathered-product)
- [software (1)](https://info.consortiex.com/blog/tag/software)
- [specialty compounding (1)](https://info.consortiex.com/blog/tag/specialty-compounding)
- [verification systems (1)](https://info.consortiex.com/blog/tag/verification-systems)

See all

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)](http://acc-dev.consortiex.com/)

- <https://twitter.com/ConsortiEX>
- <https://www.linkedin.com/company/10680398/>

*733 N Van Buren St, Ste 501*  
*Milwaukee, WI 53202*

*Office: (414) 231-4575*   
*Support: (888) 434-1442*

*Email: info@consortiex.com*

- [Homepage](https://www.consortiex.com/)
- [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
- [Blog](https://info.consortiex.com/blog)
- [Contact Us](https://www.consortiex.com/contact-us/)
- [DSCSA Compliance](https://www.consortiex.com/dscsa-compliance/)
- [Health System](https://www.consortiex.com/health-system/)
- [Magnifier™ Analytics](https://consortiex.com/consortiex-magnifier-analytics/)
- [Outsourcing Facility 503B](https://www.consortiex.com/outsourcing-facility-503b/)
- [Resources](https://info.consortiex.com/resources)

 2025 | ConsortiEX Inc. | All Rights Reserved